Scott C. Jeffrey
University of Washington Bothell(US)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, Glycosylation and Glycoproteins Research, Cancer therapeutics and mechanisms
Most-Cited Works
- → Contribution of Linker Stability to the Activities of Anticancer Immunoconjugates(2008)456 cited
- → SGN-CD33A: a novel CD33-targeting antibody–drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML(2013)383 cited
- → A Potent Anti-CD70 Antibody–Drug Conjugate Combining a Dimeric Pyrrolobenzodiazepine Drug with Site-Specific Conjugation Technology(2013)243 cited
- → Development of orally active inhibitors of protein and cellular fucosylation(2013)185 cited
- → Development and Properties of β-Glucuronide Linkers for Monoclonal Antibody−Drug Conjugates(2006)167 cited
- → Optimization of a PEGylated Glucuronide-Monomethylauristatin E Linker for Antibody–Drug Conjugates(2016)145 cited
- → Metabolic Engineering of Monoclonal Antibody Carbohydrates for Antibody–Drug Conjugation(2013)116 cited
- → Design, Synthesis, and Biological Evaluation of Antibody−Drug Conjugates Comprised of Potent Camptothecin Analogues(2009)109 cited
- → Design, Synthesis, and in Vitro Evaluation of Dipeptide-Based Antibody Minor Groove Binder Conjugates(2005)90 cited
- → Dipeptide-based highly potent doxorubicin antibody conjugates(2005)85 cited